๐ Eli Lilly $LLY pops +4% โ Q2 revenue hits $23B, Mounjaro sales up 91% YoY
Eli Lilly delivered one of the biggest pharma quarters on record: Q2 revenue came in at $23.0B (+48% YoY), crushing the $20.9B street estimate, while EPS hit $8.38 versus the $6.07 consensus. Mounjaro alone generated $9.9B in revenue and Zepbound added $4.9B in U.S. sales. Management raised the full-year revenue target to $85Bโ$87B. With Novo Nordisk stumbling today, is Lilly cementing its spot as the undisputed GLP-1 champion? Not financial advice.
โก 19 buzzing
182 views
๐ 0 subscribed